Published in Clin Infect Dis on October 14, 2005
Community-associated meticillin-resistant Staphylococcus aureus. Lancet (2010) 9.07
Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections. N Engl J Med (2015) 4.80
Excess deaths associated with tigecycline after approval based on noninferiority trials. Clin Infect Dis (2012) 2.90
Staphylococcus aureus-associated skin and soft tissue infections in ambulatory care. Emerg Infect Dis (2006) 2.43
Disease manifestations and pathogenic mechanisms of group a Streptococcus. Clin Microbiol Rev (2014) 2.20
A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a). Clin Infect Dis (2013) 2.08
Chronic critical limb ischemia. Dtsch Arztebl Int (2012) 1.86
Antimicrobial agents for complicated skin and skin-structure infections: justification of noninferiority margins in the absence of placebo-controlled trials. Clin Infect Dis (2009) 1.83
Comparative in vitro and in vivo efficacies of human simulated doses of ceftazidime and ceftazidime-avibactam against Pseudomonas aeruginosa. Antimicrob Agents Chemother (2012) 1.78
Risk factors for bacteremia in patients with limb cellulitis. Eur J Clin Microbiol Infect Dis (2006) 1.63
Results of a double-blind, randomized trial of ceftobiprole treatment of complicated skin and skin structure infections caused by gram-positive bacteria. Antimicrob Agents Chemother (2007) 1.60
Contamination of environmental surfaces with Staphylococcus aureus in households with children infected with methicillin-resistant S aureus. JAMA Pediatr (2014) 1.55
Avoidable antibiotic exposure for uncomplicated skin and soft tissue infections in the ambulatory care setting. Am J Med (2013) 1.44
Bacterial skin and soft tissue infections in adults: A review of their epidemiology, pathogenesis, diagnosis, treatment and site of care. Can J Infect Dis Med Microbiol (2008) 1.43
Necrotizing fasciitis. Can Fam Physician (2009) 1.42
Clinical pharmacodynamics of cefepime in patients infected with Pseudomonas aeruginosa. Antimicrob Agents Chemother (2009) 1.40
Antianaerobic antimicrobials: spectrum and susceptibility testing. Clin Microbiol Rev (2013) 1.37
Human simulated studies of aztreonam and aztreonam-avibactam to evaluate activity against challenging gram-negative organisms, including metallo-β-lactamase producers. Antimicrob Agents Chemother (2013) 1.36
Rapid molecular genotyping and clonal complex assignment of Staphylococcus aureus isolates by PCR coupled to electrospray ionization-mass spectrometry. J Clin Microbiol (2009) 1.31
High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria. Crit Care (2014) 1.25
Fournier's Gangrene: Current Practices. ISRN Surg (2012) 1.20
Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycin. Eur J Med Res (2010) 1.20
Analysis of the phase 3 ESTABLISH trials of tedizolid versus linezolid in acute bacterial skin and skin structure infections. Antimicrob Agents Chemother (2014) 1.19
Toward new therapeutics for skin and soft tissue infections: propargyl-linked antifolates are potent inhibitors of MRSA and Streptococcus pyogenes. PLoS One (2012) 1.16
Staphylococcus aureus in the community: colonization versus infection. PLoS One (2009) 1.16
Antimicrobial activity of the investigational pleuromutilin compound BC-3781 tested against Gram-positive organisms commonly associated with acute bacterial skin and skin structure infections. Antimicrob Agents Chemother (2012) 1.15
Efficacy of human simulated exposures of ceftaroline administered at 600 milligrams every 12 hours against phenotypically diverse Staphylococcus aureus isolates. Antimicrob Agents Chemother (2011) 1.13
National athletic trainers' association position statement: skin diseases. J Athl Train (2010) 1.12
Use of vancomycin pharmacokinetic-pharmacodynamic properties in the treatment of MRSA infections. Expert Rev Anti Infect Ther (2010) 1.11
Acinetobacter baumannii-associated skin and soft tissue infections: recognizing a broadening spectrum of disease. Surg Infect (Larchmt) (2010) 1.10
Duration of antibiotic therapy for bacteremia: a systematic review and meta-analysis. Crit Care (2011) 1.10
Epidemiology and outcomes of complicated skin and soft tissue infections in hospitalized patients. J Clin Microbiol (2011) 1.09
Mupirocin resistance related to increasing mupirocin use in clinical isolates of methicillin-resistant Staphylococcus aureus in a pediatric population. J Clin Microbiol (2010) 1.09
Advances and challenges in biosensor-based diagnosis of infectious diseases. Expert Rev Mol Diagn (2014) 1.08
Postpartum invasive group A streptococcal disease in the modern era. Infect Dis Obstet Gynecol (2008) 1.08
The treatment of cutaneous abscesses: comparison of emergency medicine providers' practice patterns. West J Emerg Med (2013) 1.06
Comparative efficacies of human simulated exposures of tedizolid and linezolid against Staphylococcus aureus in the murine thigh infection model. Antimicrob Agents Chemother (2012) 1.05
The predisposition, infection, response and organ failure (Piro) sepsis classification system: results of hospital mortality using a novel concept and methodological approach. PLoS One (2013) 1.04
Epidemiology, clinical manifestations, and treatment options for skin and soft tissue infection caused by community-acquired methicillin-resistant Staphylococcus aureus. J Am Acad Nurse Pract (2008) 1.04
Multicenter evaluation of vancomycin dosing: emphasis on obesity. Am J Med (2008) 1.03
Comparative evaluation of the tolerability of cefazolin and nafcillin for treatment of methicillin-susceptible Staphylococcus aureus infections in the outpatient setting. Clin Infect Dis (2014) 1.02
Daptomycin use in patients with osteomyelitis: a preliminary report from the EU-CORE(SM) database. J Antimicrob Chemother (2013) 1.02
Preferred treatment and prevention strategies for recurrent community-associated methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: a survey of adult and pediatric providers. Am J Infect Control (2010) 1.02
Incidence and cost of hospitalizations associated with Staphylococcus aureus skin and soft tissue infections in the United States from 2001 through 2009. BMC Infect Dis (2014) 1.01
Prospective randomized trial of empiric therapy with trimethoprim-sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2007) 1.01
In vivo activities of simulated human doses of cefepime and cefepime-AAI101 against multidrug-resistant Gram-negative Enterobacteriaceae. Antimicrob Agents Chemother (2015) 1.01
Molecular characterization of Staphylococcus aureus isolates from a 2005 clinical trial of uncomplicated skin and skin structure infections. Antimicrob Agents Chemother (2007) 1.01
Skin and soft tissue infections. Clin Infect Dis (2014) 1.00
Appropriateness of antibiotic treatment in intravenous drug users, a retrospective analysis. BMC Infect Dis (2008) 1.00
Development and validation of a bedside risk score for MRSA among patients hospitalized with complicated skin and skin structure infections. BMC Infect Dis (2012) 1.00
Comparison of the efficacy and safety of oritavancin front-loaded dosing regimens to daily dosing: an analysis of the SIMPLIFI trial. Antimicrob Agents Chemother (2011) 1.00
Dispersal of Group A streptococcal biofilms by the cysteine protease SpeB leads to increased disease severity in a murine model. PLoS One (2011) 0.99
Prevalence of High and Low Level Mupirocin Resistance among Staphylococcal Isolates from Skin Infection in a Tertiary Care Hospital. J Clin Diagn Res (2013) 0.98
Limb salvage after gas gangrene: a case report and review of the literature. World J Emerg Surg (2011) 0.98
Prevalence, severity, and treatment of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) skin and soft tissue infections in 10 medical clinics in Texas: a South Texas Ambulatory Research Network (STARNet) study. J Am Board Fam Med (2011) 0.98
Approach for initial treatment of skin and soft tissue infection. Clin Infect Dis (2014) 0.97
Predicting observation unit treatment failures in patients with skin and soft tissue infections. Int J Emerg Med (2008) 0.97
Tigecycline in the treatment of complicated intra-abdominal and complicated skin and skin structure infections. Ther Clin Risk Manag (2007) 0.95
Tigecycline (Tygacil): the first in the glycylcycline class of antibiotics. Proc (Bayl Univ Med Cent) (2006) 0.95
Trends in adverse reactions to trimethoprim-sulfamethoxazole. Pediatrics (2012) 0.93
Correlation between nasal microbiome composition and remote purulent skin and soft tissue infections. Infect Immun (2014) 0.92
Treatment failure and costs in patients with methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections: a South Texas Ambulatory Research Network (STARNet) study. J Am Board Fam Med (2013) 0.92
Dalbavancin in the treatment of complicated skin and soft-tissue infections: a review. Ther Clin Risk Manag (2008) 0.92
Tetracyclines as an oral treatment option for patients with community onset skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2007) 0.92
A peptide antagonist of CD28 signaling attenuates toxic shock and necrotizing soft-tissue infection induced by Streptococcus pyogenes. J Infect Dis (2013) 0.91
Successful treatment for carriage of methicillin-resistant Staphylococcus aureus and importance of follow-up. Antimicrob Agents Chemother (2010) 0.91
Trends in resource utilization for hospitalized children with skin and soft tissue infections. Pediatrics (2013) 0.90
Skin and skin structure infections: treatment with newer generation fluoroquinolones. Ther Clin Risk Manag (2007) 0.90
Host responses to group a streptococcus: cell death and inflammation. PLoS Pathog (2014) 0.90
Pregnancy-related group a streptococcal infections: temporal relationships between bacterial acquisition, infection onset, clinical findings, and outcome. Clin Infect Dis (2013) 0.89
Has the emergence of community-associated methicillin-resistant Staphylococcus aureus increased trimethoprim-sulfamethoxazole use and resistance?: a 10-year time series analysis. Antimicrob Agents Chemother (2012) 0.89
Population pharmacokinetics of piperacillin/tazobactam in neonates and young infants. Eur J Clin Pharmacol (2013) 0.89
Antimicrobial prophylaxis in adults. Mayo Clin Proc (2011) 0.88
Skin and soft tissue infections and associated complications among commercially insured patients aged 0-64 years with and without diabetes in the U.S. PLoS One (2013) 0.88
Role of Diffusion Weighted Imaging in Musculoskeletal Infections: Current Perspectives. Eur Radiol (2016) 0.88
Impact of Antimicrobial Stewardship Program (ASP) on Outcomes in Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) in an Acute-Tertiary Care Hospital. Infect Dis Ther (2015) 0.87
Rapid Emergence and Evolution of Staphylococcus aureus Clones Harboring fusC-Containing Staphylococcal Cassette Chromosome Elements. Antimicrob Agents Chemother (2016) 0.87
Clinical and molecular characteristics of invasive and noninvasive skin and soft tissue infections caused by group A Streptococcus. J Clin Microbiol (2011) 0.87
Pelvic surgical site infections in gynecologic surgery. Infect Dis Obstet Gynecol (2015) 0.86
Antibiotic susceptibility and genomic variations in Staphylococcus aureus associated with Skin and Soft Tissue Infection (SSTI) disease groups. BMC Infect Dis (2016) 0.86
How to treat skin infections, including MRSA, in 2008. Medscape J Med (2008) 0.86
In vivo activity of ceftobiprole in murine skin infections due to Staphylococcus aureus and Pseudomonas aeruginosa. Antimicrob Agents Chemother (2009) 0.86
Moxifloxacin in the treatment of skin and skin structure infections. Ther Clin Risk Manag (2006) 0.85
Factors associated with decision to hospitalize emergency department patients with skin and soft tissue infection. West J Emerg Med (2014) 0.85
Incidence of skin and soft tissue infections in ambulatory and inpatient settings, 2005-2010. BMC Infect Dis (2015) 0.85
Skin and soft tissue infections in hospitalized and critically ill patients: a nationwide population-based study. BMC Infect Dis (2010) 0.84
Is Community-Acquired Methicillin-Resistant Staphylococcus aureus Coverage Needed for Cellulitis? Infect Dis Ther (2013) 0.84
Antibiotic optimization in the difficult-to-treat patient with complicated intra-abdominal or complicated skin and skin structure infections: focus on tigecycline. Ther Clin Risk Manag (2010) 0.84
The efficacy and safety of daptomycin vs. vancomycin for the treatment of cellulitis and erysipelas. Int J Clin Pract (2009) 0.84
Phase II clinical study of BC-3781, a pleuromutilin antibiotic, in treatment of patients with acute bacterial skin and skin structure infections. Antimicrob Agents Chemother (2013) 0.84
Lessons for control of heroin-associated anthrax in Europe from 2009-2010 outbreak case studies, London, UK. Emerg Infect Dis (2014) 0.84
The efficacy and safety of linezolid and glycopeptides in the treatment of Staphylococcus aureus infections. PLoS One (2013) 0.83
Resistance and the management of complicated skin and skin structure infections: the role of ceftobiprole. Ther Clin Risk Manag (2010) 0.83
Nitric oxide-releasing poly(lactic-co-glycolic acid)-polyethylenimine nanoparticles for prolonged nitric oxide release, antibacterial efficacy, and in vivo wound healing activity. Int J Nanomedicine (2015) 0.83
Critical pathways for post-emergency outpatient diagnosis and treatment: tools to improve the value of emergency care. Acad Emerg Med (2011) 0.83
[Sensitivity profile of Staphylococcus spp. and Streptococcus spp. isolated from toys used in a teaching hospital playroom]. Rev Paul Pediatr (2014) 0.83
Necrotizing Soft Tissue Infections: Surgeon's Prospective. Int J Inflam (2013) 0.83
Clinical Study of an Online Tool for Standardizing Hospital Care. J Healthc Qual (2017) 0.83
Neonatal pustular dermatosis: an overview. Indian J Dermatol (2015) 0.82
Tuberculous pyomyositis: a rare but serious diagnosis. Case Rep Med (2013) 0.81
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis (2007) 24.91
Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med (2005) 23.85
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis (2009) 18.19
Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol (2010) 17.99
Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis (2008) 16.51
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis (2006) 14.63
International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis (2011) 12.29
Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis (2011) 11.49
2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol (2006) 11.26
The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis (2008) 9.57
Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis (2011) 9.37
Community-associated meticillin-resistant Staphylococcus aureus. Lancet (2010) 9.07
Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis (2012) 8.56
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med (2006) 8.20
Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis (2005) 6.85
Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis (2011) 6.71
Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis (2010) 6.70
Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis (2010) 6.59
Guidelines for treatment of candidiasis. Clin Infect Dis (2003) 5.55
Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis (2007) 5.51
Treatment of tuberculosis. MMWR Recomm Rep (2003) 5.41
Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis (2003) 5.21
Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med (2008) 5.13
Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant (2009) 5.10
Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis (2001) 4.94
Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections. N Engl J Med (2015) 4.80
Practice guidelines for the management of infectious diarrhea. Clin Infect Dis (2001) 4.49
Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America. Clin Infect Dis (2002) 4.43
Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis (2004) 4.40
Community-associated MRSA--resistance and virulence converge. N Engl J Med (2005) 4.15
10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America. Clin Infect Dis (2013) 4.07
Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A (2009) 3.89
Coccidioidomycosis. Clin Infect Dis (2005) 3.88
American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: controlling tuberculosis in the United States. Am J Respir Crit Care Med (2005) 3.82
The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis (2008) 3.79
Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS). Infect Control Hosp Epidemiol (2012) 3.76
Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology (2009) 3.73
The arginine catabolic mobile element and staphylococcal chromosomal cassette mec linkage: convergence of virulence and resistance in the USA300 clone of methicillin-resistant Staphylococcus aureus. J Infect Dis (2008) 3.68
Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America. Crit Care Med (2008) 3.67
Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis (2014) 3.67
Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR Recomm Rep (2005) 3.54
Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clin Infect Dis (2002) 3.53
National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med (2008) 3.46
Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis (2012) 3.41
Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. J Clin Invest (2009) 3.24
2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis (2012) 3.22
Principles of appropriate antibiotic use for acute rhinosinusitis in adults: background. Ann Intern Med (2001) 3.15
Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proc Natl Acad Sci U S A (2010) 3.05
Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. J Clin Oncol (2008) 2.99
Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis (2003) 2.92
Diagnosis and treatment of diabetic foot infections. Clin Infect Dis (2004) 2.92
Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods. Antimicrob Agents Chemother (2003) 2.80
Ciprofloxacin plus piperacillin compared with tobramycin plus piperacillin as empirical therapy in febrile neutropenic patients. A randomized, double-blind trial. Ann Intern Med (2002) 2.70
Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect (Larchmt) (2010) 2.67
Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis (2012) 2.67
Contribution of Panton-Valentine leukocidin in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. PLoS One (2008) 2.62
Global changes in Staphylococcus aureus gene expression in human blood. PLoS One (2011) 2.61
The practice of travel medicine: guidelines by the Infectious Diseases Society of America. Clin Infect Dis (2006) 2.60
Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the Infectious Diseases Society of America. Clin Infect Dis (2013) 2.58
Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. Blood (2007) 2.49
Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens. Clin Infect Dis (2004) 2.46
IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis (2012) 2.43
A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004-2005. Clin Infect Dis (2008) 2.35
Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis (2008) 2.35
Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma. J Clin Oncol (2007) 2.34
Executive summary: diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis (2013) 2.22
Risk factors for Toxoplasma gondii infection in the United States. Clin Infect Dis (2009) 2.20
Weight loss and survival in HIV-positive patients in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2002) 2.09
Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. MMWR Recomm Rep (2004) 2.05
The human immune response to streptococcal extracellular antigens: clinical, diagnostic, and potential pathogenetic implications. Clin Infect Dis (2010) 2.04
Vancomycin treatment failure associated with heterogeneous vancomycin-intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis. Antimicrob Agents Chemother (2003) 2.02
Role of SraP, a Serine-Rich Surface Protein of Staphylococcus aureus, in binding to human platelets. Infect Immun (2005) 1.99
Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents. J Clin Microbiol (2007) 1.97
Microbiology of animal bite wound infections. Clin Microbiol Rev (2011) 1.96
Serum cardiac troponin I in acute rheumatic fever. Am J Cardiol (2002) 1.95
Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association. Circulation (2015) 1.95
Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study. Transplantation (2006) 1.94
Importance of perioperative glycemic control in general surgery: a report from the Surgical Care and Outcomes Assessment Program. Ann Surg (2013) 1.93
Guidelines for infectious diseases specialists serving as expert witnesses. Clin Infect Dis (2005) 1.92
Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults: background. Ann Intern Med (2001) 1.89
Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis (2007) 1.87
Recent developments for diagnosis of toxoplasmosis. J Clin Microbiol (2004) 1.86
Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infections. Clin Infect Dis (2011) 1.83
Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus. Clin Infect Dis (2008) 1.82
The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro. Proc Natl Acad Sci U S A (2010) 1.82
2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis (2014) 1.81
Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic. Clin Infect Dis (2009) 1.80
Streptococcal infection and exacerbations of childhood tics and obsessive-compulsive symptoms: a prospective blinded cohort study. Pediatrics (2008) 1.79
Risk factors for cardiovascular disease in children infected with human immunodeficiency virus-1. J Pediatr (2008) 1.78
Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders. Biol Blood Marrow Transplant (2008) 1.75
Diagnosis of strep throat in adults: are clinical criteria really good enough? Clin Infect Dis (2002) 1.74
2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis (2013) 1.69